Literature DB >> 1409382

Formation of the racemic compound of ephedrine base from a physical mixture of its enantiomers in the solid, liquid, solution, or vapor state.

S P Duddu1, D J Grant.   

Abstract

Physical mixtures (conglomerates) of the two enantiomers of ephedrine base, each containing 0.5% (w/w) of water, were observed to be converted to the 1:1 racemic compound in the solid, liquid, solution, or vapor state. From a geometrically mixed racemic conglomerate of particle size 250-300 microns (50-60 mesh), the formation of the racemic compound follows second-order kinetics (first order with respect to each enantiomer), with a rate constant of 392 mol-1 hr-1 at 22 degrees C. The reaction appears to proceed via the vapor phase as indicated by the growth of the crystals of the racemic compound between diametrically separated crystals of the two enantiomers in a glass petri dish. The observed kinetics of conversion in the solid state are explained by a homogeneous reaction model via the vapor and/or liquid states. Formation of the racemic compound from the crystals of ephedrine enantiomers in the solution state may explain why Schmidt et al. (Pharm. Res. 5:391-395, 1988) observed a consistently lower aqueous solubility of the mixture than of the pure enantiomers. The solid phase in equilibrium with the solution at the end of the experiment was found to be the racemic compound, whose melting point and heat of fusion are higher than those of the enantiomers. An association reaction, of measurable rate, between the opposite enantiomers in a binary mixture in the solid, liquid, solution, or vapor state to form the racemic compound may be more common than is generally realized.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1409382     DOI: 10.1023/a:1015870915132

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  6 in total

Review 1.  Crystallographic consequences of molecular dissymmetry.

Authors:  H G Brittain
Journal:  Pharm Res       Date:  1990-07       Impact factor: 4.200

2.  A program package for simulation and parameter estimation in pharmacokinetic systems.

Authors:  D Z D'Argenio; A Schumitzky
Journal:  Comput Programs Biomed       Date:  1979-03

3.  Utilization of an enantiomer as a solution to a pharmaceutical problem: application to solubilization of 1,2-di(4-piperazine-2,6-dione)propane.

Authors:  A J Repta; M J Baltezor; P C Bansal
Journal:  J Pharm Sci       Date:  1976-02       Impact factor: 3.534

4.  Thermodynamics in the prediction of the solubilities of binary mixtures of the diastereoisomers and enantiomers of ephedrine.

Authors:  W F Schmidt; W Porter; J T Carstensen
Journal:  Pharm Res       Date:  1988-06       Impact factor: 4.200

5.  Effect of enantiomeric purity on solubility determination of dexclamol hydrochloride.

Authors:  S T Liu; A Hurwitz
Journal:  J Pharm Sci       Date:  1978-05       Impact factor: 3.534

6.  Solid-state acetylation of codeine phosphate by aspirin.

Authors:  R N Galante; A J Visalli; D M Patel
Journal:  J Pharm Sci       Date:  1979-12       Impact factor: 3.534

  6 in total
  3 in total

1.  Quantitative relationship between solubility, initial dissolution rate and heat of solution of chiral drugs.

Authors:  E Yonemochi; Y Yoshihashi; K Terada
Journal:  Pharm Res       Date:  2000-01       Impact factor: 4.200

2.  Effects of configuration around the chiral carbon atoms on the crystal properties of ephedrinium and pseudoephedrinium salicylates.

Authors:  S P Duddu; D J Grant
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

3.  Crystallization Behavior and Crystallographic Properties of dl-Arabinose and dl-Xylose Diastereomer Sugars.

Authors:  Bradley Tyson; Christopher M Pask; Neil George; Elena Simone
Journal:  Cryst Growth Des       Date:  2022-01-12       Impact factor: 4.076

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.